drugset / Trial / NCT00661635

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

NCT00661635

Phase 3 Completed 490 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the analgesic efficacy, general safety, and effects on health outcome measures and opioid-related symptoms of 2 valdecoxib dosing regimens compared with placebo in patients with moderate or severe pain following laparoscopic cholecystectomy surgery.

Timeline

Start
2002-11
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator valdecoxib Small molecule 20 mg Oral

Indications